CanSino Biologics
(SEHK) 6185
CanSino Biologics Financials at a Glance
Market Cap
$8.16B
Revenue (TTM)
$1.06B
Net Income (TTM)
$27.15M
EPS (TTM)
$0.12
P/E Ratio
271.71
Dividend
$0.00
Beta (Volatility)
0.33 (Low)
Dividend
$0.00
Beta (Volatility)
0.33 (Low)
Price
$33.04
Volume
1,053,000
Open
$33.54
Price
$33.04
Volume
1,053,000
Open
$33.54
Previous Close
$33.82
Daily Range
$32.42 - $33.66
52-Week Range
$25.25 - $56.55
Dividend
$0.00
Beta (Volatility)
0.33 (Low)
Price
$33.04
Volume
1,053,000
Open
$33.54
Previous Close
$33.82
Daily Range
$32.42 - $33.66
52-Week Range
$25.25 - $56.55
6185 News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CanSino Biologics
Industry
Biotechnology
Sector
Health CareEmployees
1,134
CEO
Xue Feng Yu, PhD
Website
www.cansinotech.comHeadquarters
Tianjin, 300457, CN
6185 Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
2%
Net Income Margin
3%
Return on Equity
57%
Return on Capital
0%
Return on Assets
0%
Earnings Yield
0.37%
Dividend Yield
0.00%
Payout Ratio
1.31%
Stock Overview
Market Cap
$8.16B
Shares Outstanding
247.04M
Volume
1.05M
Short Interest
0.00%
Avg. Volume
974.49K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$23.29M
EBITDA
$23.29M
Operating Cash Flow
$168.79M
Capital Expenditure
$457.64M
Free Cash Flow
$626.42M
Cash & ST Invst.
$3.20B
Total Debt
$2.01B
CanSino Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$369.80M
+32.4%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$8.16B
N/A
Market Cap/Employee
$7.39M
N/A
Employees
1,105
N/A
Net Income
$12.72M
+108.1%
EBITDA
$14.70M
+109.4%
Quarterly Fundamentals
Net Cash
$1.04B
-11.8%
Accounts Receivable
$737.73M
+8.8%
Inventory
$357.84M
+3.7%
Long Term Debt
$1.06B
+9.0%
Short Term Debt
$365.01M
-67.7%
Return on Assets
0.00%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$15.00M
+89.0%
Operating Cash Flow
$30.91M
+142.2%